Nicholas Stevers

City College of San Francisco — United States

Medicine · Health Sciences

14h-index706citations74works11.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Telomeres, Telomerase, and Senescence(17), Glioma Diagnosis and Treatment(14), CAR-T cell therapy research(11), Immunotherapy and Immune Responses(10), Cancer Research and Treatments(9)

Publications74 total

TMIC-110. Role of LRRC25 in local and systemic immunosuppression and its reversal
Neuro-Oncology·2025Open Access
EPCO-23. MOLECULAR CHARACTERIZATION OF CRISPROFF EPIGENETIC EDITOR ACTIVITY REVEALS MUTANT ALLELE-SPECIFIC <i>TERT</i> REPRESSION IN GLIOBLASTOMA
Neuro-Oncology·2025Open Access
EXTH-77. An AI-engineered bioPROTAC reverses immortality of <i>TERT</i> promoter mutant tumors
Neuro-Oncology·2025Open Access
EXTH-52. Spatially Resolved Antigenic Landscapes In Low-grade Glioma Reveal Targets For Personalized Immunotherapy
Neuro-Oncology·2025Open Access
RBIO-10. Targeting telomere maintenance sensitizes group 3 medulloblastomas to ionizing radiation
Neuro-Oncology·2025Open Access
The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversible
Molecular Cell·2025· 3 cited
Tumor-wide RNA splicing aberrations and their potential as therapeutic neoantigen targets.
Journal of Clinical Oncology·2025
Abstract 3894: Three-dimensional whole tumor genomic analysis redefine intratumor heterogeneity of gliomas, with implications for early tumorigenesis
Cancer Research·2025
Abstract 4250: Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens across cancers
Cancer Research·2025· 1 cited
Tumour-wide RNA splicing aberrations generate actionable public neoantigens
Nature·2025· 43 citedOpen Access
EXTH-68. EPIGENETIC EDITING BY MRNA-BASED CRISPROFF ENABLES FLEXIBLE AND DURABLE TARGETING OF GLIOBLASTOMA DRIVERS MGMT AND TERT
Neuro-Oncology·2024Open Access
154 Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens across various cancer types
Regular and Young Investigator Award Abstracts·2024Open Access
155 Sub-clonal antigenic heterogeneity mediates immune evasion in low-grade gliomas
Regular and Young Investigator Award Abstracts·2024Open Access
IMMU-55. TUMOR-WIDE RNA SPLICING ABERRATIONS GENERATE IMMUNOGENIC PUBLIC NEOANTIGENS IN GLIOBLASTOMAS AND OTHER CANCER TYPES
Neuro-Oncology·2024Open Access
Hyperpolarized [1-13C] Gluconolactone Can Visualize TERT Silencing Directly or via the Upstream Transcriptional Factor GABPB1 in Glioblastoma
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2024
Abstract 3907: Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types
Cancer Research·2024
Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma
Scientific Reports·2024· 12 citedOpen Access
Telomeres in glioma: Maintenance mechanisms to therapeutic potential
Neuro-Oncology·2024· 2 citedOpen Access
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective
Cell·2024· 158 citedOpen Access
Whole tumor analysis reveals early origin of the <i>TERT</i> promoter mutation and intercellular heterogeneity in <i>TERT</i> expression
Neuro-Oncology·2023· 15 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

J Costello(35), Chibo Hong(18), Darwin Kwok(12), Duxin Sun(12), Carter J. Barger(12), Anny Shai(11), Joanna J. Phillips(11), Georgios Batsios(11), Anne Marie Gillespie(11), Pavithra Viswanath(11), Hideho Okada(10), Sabrina M. Ronen(10), Susan M. Chang(8), Senthilnath Lakshmanachetty(8), Marco Gallus(7), Meryssa Tran(7), Radhika Mathur(6), Stephanie Hilz(6), Nadia Grishanina(6), Shawn L. Hervey‐Jumper(6)